| Medical Science Liaison-HCC/BTC-Beijing | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-LC-Guangzhou | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-HTN-Guangzhou | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-HTN-Guangzhou | AstraZeneca | | 2026-06-25 |
| Senior Physician I/II (Early Oncology) | AstraZeneca | Shanghai | 2026-06-25 |
| Medical Advisor-Inhale | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-Severe Asthma-Beijing | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-LC-Beijing | AstraZeneca | | 2026-06-25 |
| Clinical Operations Program Associate Manager | AstraZeneca | Shanghai | 2026-06-25 |
| Medical Science Liaison-NF1-Guangzhou/Shenzhen | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-gMG/NMOSD-Chongqing | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Immu-Taiyuan | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-COPD-้ฟๆฒ | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-COPD-ๆตๅ | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-COPD-็ฆๅท | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-COPD-ๆญๅท | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Immu-Changsha | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-GC-Shanghai | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Biologics-Severe Asthma-Jinan | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-Inhaled-Wuhan | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-LC-Haerbin | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-BC-Beijing | AstraZeneca | | 2026-06-25 |
| Medical Science Liaison-BC-Chongqing | AstraZeneca | | 2026-06-25 |
| Senior Physician I/II (GU) | AstraZeneca | Shanghai | 2026-06-25 |
| Medical Science Liaison-NF 1-Chongqing | AstraZeneca | | 2026-06-25 |
| Head of Integrated Sales, FMCG/Cold Chain/Healthcare & Customer Acquisition | A.P. Mรธller-Mรฆrsk | Shanghai | 2026-06-25 |
| Clinical Medical Manager | Novo Nordisk | Beijing | 2026-06-25 |